MSD has announced the launch of VivaLAX, a new brand of laxative that assists in providing
gentle predictable relief from constipation. Australians spend about $60 million per year on
laxatives and it is estimated that one in five Australians suffer from
this condition. VivaLAX is the number one selling laxative brand in
the USA. With its gentle action and convenient solubility, VivaLAX
contains a single ingredient Macrogol 3350 (1g/g), is taken as a
once daily dose and is also sugar, gluten and preservative free.
Stockist: 1800 777 950
RRP: $8.99 7s bottle, $19.99 30s bottle, $13.99 10s sachet
Website: www.vivalax.com.auThe above article was sent to subscribers in Pharmacy Daily's issue from 02 Apr 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Apr 14
RESPONDING to the findings from the Royal Commission into Aged Care Quality and Safety, a recent government initiative aims to improve medication management in residential aged care facilities by introducing on-site pharmacists.
RESEARCHERS at Charles Darwin University (CDU) are advancing a novel drug delivery system that could potentially eliminate the need for injections to treat various chronic diseases.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.